These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24572788)

  • 1. Long-term correction of biochemical and neurological abnormalities in MLD mice model by neonatal systemic injection of an AAV serotype 9 vector.
    Miyake N; Miyake K; Asakawa N; Yamamoto M; Shimada T
    Gene Ther; 2014 Apr; 21(4):427-33. PubMed ID: 24572788
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global diffuse distribution in the brain and efficient gene delivery to the dorsal root ganglia by intrathecal injection of adeno-associated viral vector serotype 1.
    Iwamoto N; Watanabe A; Yamamoto M; Miyake N; Kurai T; Teramoto A; Shimada T
    J Gene Med; 2009 Jun; 11(6):498-505. PubMed ID: 19338016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ex vivo cell-mediated gene therapy for metachromatic leukodystrophy using neurospheres.
    Kawabata K; Migita M; Mochizuki H; Miyake K; Igarashi T; Fukunaga Y; Shimada T
    Brain Res; 2006 Jun; 1094(1):13-23. PubMed ID: 16729983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Partial cure of established disease in an animal model of metachromatic leukodystrophy after intracerebral adeno-associated virus-mediated gene transfer.
    Sevin C; Verot L; Benraiss A; Van Dam D; Bonnin D; Nagels G; Fouquet F; Gieselmann V; Vanier MT; De Deyn PP; Aubourg P; Cartier N
    Gene Ther; 2007 Mar; 14(5):405-14. PubMed ID: 17093507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AAV1 mediated co-expression of formylglycine-generating enzyme and arylsulfatase a efficiently corrects sulfatide storage in a mouse model of metachromatic leukodystrophy.
    Kurai T; Hisayasu S; Kitagawa R; Migita M; Suzuki H; Hirai Y; Shimada T
    Mol Ther; 2007 Jan; 15(1):38-43. PubMed ID: 17164773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracerebroventricular enzyme infusion corrects central nervous system pathology and dysfunction in a mouse model of metachromatic leukodystrophy.
    Stroobants S; Gerlach D; Matthes F; Hartmann D; Fogh J; Gieselmann V; D'Hooge R; Matzner U
    Hum Mol Genet; 2011 Jul; 20(14):2760-9. PubMed ID: 21515587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coexpression of formylglycine-generating enzyme is essential for synthesis and secretion of functional arylsulfatase A in a mouse model of metachromatic leukodystrophy.
    Takakusaki Y; Hisayasu S; Hirai Y; Shimada T
    Hum Gene Ther; 2005 Aug; 16(8):929-36. PubMed ID: 16076251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of adult metachromatic leukodystrophy model mice using intrathecal administration of type 9 AAV vector encoding arylsulfatase A.
    Miyake N; Miyake K; Sakai A; Yamamoto M; Suzuki H; Shimada T
    Sci Rep; 2021 Oct; 11(1):20513. PubMed ID: 34654893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction of brain oligodendrocytes by AAVrh.10 intracerebral gene therapy in metachromatic leukodystrophy mice.
    Piguet F; Sondhi D; Piraud M; Fouquet F; Hackett NR; Ahouansou O; Vanier MT; Bieche I; Aubourg P; Crystal RG; Cartier N; Sevin C
    Hum Gene Ther; 2012 Aug; 23(8):903-14. PubMed ID: 22642214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors.
    Miyake N; Miyake K; Yamamoto M; Hirai Y; Shimada T
    Brain Res; 2011 May; 1389():19-26. PubMed ID: 21397590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme replacement in the CSF to treat metachromatic leukodystrophy in mouse model using single intracerebroventricular injection of self-complementary AAV1 vector.
    Hironaka K; Yamazaki Y; Hirai Y; Yamamoto M; Miyake N; Miyake K; Okada T; Morita A; Shimada T
    Sci Rep; 2015 Aug; 5():13104. PubMed ID: 26283284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone marrow stem cell-based gene transfer in a mouse model for metachromatic leukodystrophy: effects on visceral and nervous system disease manifestations.
    Matzner U; Hartmann D; Lüllmann-Rauch R; Coenen R; Rothert F; Månsson JE; Fredman P; D'Hooge R; De Deyn PP; Gieselmann V
    Gene Ther; 2002 Jan; 9(1):53-63. PubMed ID: 11850723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intracerebral adeno-associated virus-mediated gene transfer in rapidly progressive forms of metachromatic leukodystrophy.
    Sevin C; Benraiss A; Van Dam D; Bonnin D; Nagels G; Verot L; Laurendeau I; Vidaud M; Gieselmann V; Vanier M; De Deyn PP; Aubourg P; Cartier N
    Hum Mol Genet; 2006 Jan; 15(1):53-64. PubMed ID: 16311251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful transduction of oligodendrocytes and restoration of arylsulfatase A deficiency in metachromatic leukodystrophy fibroblasts using an adenovirus vector.
    Ohashi T; Watabe K; Sato Y; Saito I; Barranger JA; Eto Y
    Gene Ther; 1995 Sep; 2(7):443-9. PubMed ID: 7584122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lysosomal sulfatide storage in the brain of arylsulfatase A-deficient mice: cellular alterations and topographic distribution.
    Wittke D; Hartmann D; Gieselmann V; Lüllmann-Rauch R
    Acta Neuropathol; 2004 Oct; 108(4):261-71. PubMed ID: 15322834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of tolerance to human arylsulfatase A in a mouse model of metachromatic leukodystrophy.
    Matzner U; Matthes F; Herbst E; Lüllmann-Rauch R; Callaerts-Vegh Z; D'Hooge R; Weigelt C; Eistrup C; Fogh J; Gieselmann V
    Mol Med; 2007; 13(9-10):471-9. PubMed ID: 17660863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A spontaneously immortalized Schwann cell line to study the molecular aspects of metachromatic leukodystrophy.
    Saravanan K; Büssow H; Weiler N; Gieselmann V; Franken S
    J Neurosci Methods; 2007 Apr; 161(2):223-33. PubMed ID: 17204333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracerebral Gene Therapy Using AAVrh.10-hARSA Recombinant Vector to Treat Patients with Early-Onset Forms of Metachromatic Leukodystrophy: Preclinical Feasibility and Safety Assessments in Nonhuman Primates.
    Zerah M; Piguet F; Colle MA; Raoul S; Deschamps JY; Deniaud J; Gautier B; Toulgoat F; Bieche I; Laurendeau I; Sondhi D; Souweidane MM; Cartier-Lacave N; Moullier P; Crystal RG; Roujeau T; Sevin C; Aubourg P
    Hum Gene Ther Clin Dev; 2015 Jun; 26(2):113-24. PubMed ID: 25758611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of enzyme replacement therapy in an aggravated mouse model of metachromatic leukodystrophy declines with age.
    Matthes F; Stroobants S; Gerlach D; Wohlenberg C; Wessig C; Fogh J; Gieselmann V; Eckhardt M; D'Hooge R; Matzner U
    Hum Mol Genet; 2012 Jun; 21(11):2599-609. PubMed ID: 22388935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arylsulfatase A Overexpressing Human iPSC-derived Neural Cells Reduce CNS Sulfatide Storage in a Mouse Model of Metachromatic Leukodystrophy.
    Doerr J; Böckenhoff A; Ewald B; Ladewig J; Eckhardt M; Gieselmann V; Matzner U; Brüstle O; Koch P
    Mol Ther; 2015 Sep; 23(9):1519-31. PubMed ID: 26061647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.